Wedbush Raises Cognyte Software (NASDAQ:CGNT) Price Target to $9.00

Cognyte Software (NASDAQ:CGNT – Free Report) had its price target hoisted by Wedbush from $8.00 to $9.00 in a research report released on Thursday, Benzinga reports. Wedbush currently has a neutral rating on the medical device company’s stock. A number of other analysts also recently weighed in on the company. Evercore ISI increased their price […]

Leave a Reply

Your email address will not be published.

Previous post Milestone Scientific (NYSE:MLSS) Now Covered by Analysts at StockNews.com
Next post AGTZ Twin Tail Redefines Automotive Luxury